(Q27851664)

English

A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations

scientific article

Statements

A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations (English)
1 reference
Gregory J Riely
0 references
Melissa L Johnson
0 references
Chanoa Medina
0 references
Naiyer A Rizvi
0 references
Vincent A Miller
0 references
Mark G Kris
0 references
M Catherine Pietanza
0 references
Christopher G Azzoli
0 references
Lee M Krug
0 references
Michelle S Ginsberg
0 references
August 2011
0 references
6
0 references
1435-7
0 references
8
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit